Quick Answer
FENNEC PHARMACEUTICALS INC. reported R&D Expense of $250.0 thousand for fiscal year 2025.
FENNEC PHARMACEUTICALS INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $250.0K | -18.6% |
| 2024 | $307.0K | +448.2% |
| 2023 | $56.0K | -98.4% |
| 2022 | $3.53M | -29.1% |
| 2021 | $4.98M | -2.4% |
| 2020 | $5.11M | -9.0% |
| 2019 | $5.61M | +12.0% |
| 2018 | $5.01M | +158.7% |
| 2017 | $1.94M | +310.2% |
| 2016 | $472.0K | +84.4% |
| 2015 | $256.0K | -28.3% |
| 2014 | $357.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $29.0K | -70.1% | -72.9% |
| June 30, 2025 | $107.0K | -31.8% | +13.8% |
| March 31, 2025 | $94.0K | +3033.3% | -3.1% |
| September 30, 2024 | $97.0K | +708.3% | -38.2% |
| June 30, 2024 | $157.0K | +1862.5% | +5133.3% |
| March 31, 2024 | $3.0K | -25.0% | -75.0% |
| September 30, 2023 | $12.0K | -98.6% | +50.0% |
| June 30, 2023 | $8.0K | -99.3% | +100.0% |
- FENNEC PHARMACEUTICALS INC. showed a decrease of -18.6% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, FENNEC PHARMACEUTICALS INC.’s r&d expense has declined by 30.0% (from $357.0 thousand to $250.0 thousand).
- The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: